Coronary Syndrome: Clinical Treatment, Prevention and Management for Better Outcomes
This reprint focuses on recent advances in the clinical care of patients with acute and chronic coronary syndromes. We must accumulate novel scientific and clinical knowledge in this field to develop seamless treatments and preventive strategies for this patient population. Furthermore, accumulated...
Saved in:
Other Authors: | , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_101412 | ||
005 | 20230714 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20230714s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-7913-9 | ||
020 | |a 9783036579122 | ||
020 | |a 9783036579139 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-7913-9 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
072 | 7 | |a MJD |2 bicssc | |
100 | 1 | |a Node, Koichi |4 edt | |
700 | 1 | |a Tanaka, Atsushi |4 edt | |
700 | 1 | |a Node, Koichi |4 oth | |
700 | 1 | |a Tanaka, Atsushi |4 oth | |
245 | 1 | 0 | |a Coronary Syndrome: Clinical Treatment, Prevention and Management for Better Outcomes |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (202 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a This reprint focuses on recent advances in the clinical care of patients with acute and chronic coronary syndromes. We must accumulate novel scientific and clinical knowledge in this field to develop seamless treatments and preventive strategies for this patient population. Furthermore, accumulated data have implicated that there are some residual risk factors for coronary syndromes, and the clinical management of cardiovascular/non-cardiovascular complications associated with coronary syndromes is also a critical concern. We hope that this reprint will facilitate the management of future patients with coronary syndromes; however, further research is still required. It is also our hope that this reprint will promote future research to enable a better understanding of the clinical practice of coronary syndromes. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
650 | 7 | |a Cardiovascular medicine |2 bicssc | |
653 | |a statin | ||
653 | |a myocardial infarction | ||
653 | |a renal function | ||
653 | |a coronary CT angiography | ||
653 | |a subtraction | ||
653 | |a fractional flow reserve | ||
653 | |a coronary artery disease | ||
653 | |a Agatston score | ||
653 | |a uric acid | ||
653 | |a endothelial function | ||
653 | |a ischemic heart disease | ||
653 | |a ischemia with no obstructive coronary artery disease | ||
653 | |a angioplasty | ||
653 | |a drug-eluting stents | ||
653 | |a non-ST-elevation myocardial infarction | ||
653 | |a multivessel disease | ||
653 | |a acute coronary syndrome | ||
653 | |a chronic coronary syndrome | ||
653 | |a xanthine oxidoreductase | ||
653 | |a coronary artery spasm | ||
653 | |a gender differences | ||
653 | |a vasospastic angina | ||
653 | |a microvascular spasm | ||
653 | |a microvascular vasodilatory function | ||
653 | |a high coronary thrombus burden | ||
653 | |a tissue plasminogen activator | ||
653 | |a catheter-directed thrombolysis | ||
653 | |a olmesartan | ||
653 | |a amlodipine | ||
653 | |a rosuvastatin | ||
653 | |a single pill combination | ||
653 | |a phase III clinical trial | ||
653 | |a computed tomography | ||
653 | |a computed tomography perfusion | ||
653 | |a myocardial perfusion abnormality | ||
653 | |a aspirin | ||
653 | |a clopidogrel | ||
653 | |a prasugrel | ||
653 | |a P2Y12 inhibitor | ||
653 | |a bleeding | ||
653 | |a nitrate | ||
653 | |a vasodilator | ||
653 | |a biomarker | ||
653 | |a mortality | ||
653 | |a risk-score model | ||
653 | |a n/a | ||
653 | |a NGAL | ||
653 | |a contrast-induced acute kidney injury | ||
653 | |a percutaneous coronary intervention | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7509 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/101412 |7 0 |z DOAB: description of the publication |